[1]廖萍,夏智勇,蒋静,等.高强度聚焦超声联合宫腔镜治疗直径4~8 cm的Ⅱ型黏膜下肌瘤12例分析[J].中国计划生育和妇产科,2020,(9):72-75,94.
　LIAO Ping,XIA Zhiyong,JIANG Jing,et al.Highintensity focused ultrasound combined with hysteroscope for the treatment of 12 cases of type Ⅱ submucous myoma with diameter 4~8 cm[J].Chinese Journal of Family Planning & Gynecotokology,2020,(9):72-75,94.
点击复制

高强度聚焦超声联合宫腔镜治疗直径4~8 cm的Ⅱ型黏膜下肌瘤12例分析
分享到：

《中国计划生育和妇产科》[ISSN:1674-4020/CN:51-1708/R]

卷:
期数:
2020年9期
页码:
72-75,94
栏目:
论著与临床
出版日期:
2020-09-25

文章信息/Info

Title:
Highintensity focused ultrasound combined with hysteroscope for the treatment of 12 cases of type Ⅱ submucous myoma with diameter 4~8 cm
作者:
廖萍; 夏智勇; 蒋静; 曾玉华; 周洪贵*
川北医学院附属医院妇产科
Author(s):
LIAO Ping; XIA Zhiyong; JIANG Jing; ZENG Yuhua; ZHOU Honggui*
Department of Obstetrics and Gynecology,Affiliated Hospital of North Sichuan Medical College, Nanchong Sichuan 637000,P.R.China
关键词:
Ⅱ型黏膜下肌瘤; 高强度聚焦超声; 宫腔镜下子宫肌瘤电切术
Keywords:
type II submucous myoma; high intensity focused ultrasound; hysteroscopic myomectomy
分类号:
R 713.4
摘要:
目的探讨高强度聚焦超声（high intensity focused ultrasound，HIFU）联合宫腔镜治疗直径＞4 cm的Ⅱ型黏膜下肌瘤的有效性及安全性。方法将川北医学院附属医院2019年1~6月经阴道超声或磁共振诊断的12例直径4~8 cm的Ⅱ型黏膜下肌瘤行HIFU治疗，术后3月分析肌瘤变化，行宫腔镜下子宫肌瘤电切术，记录HIFU前、后患者的血红蛋白、肌瘤最大径、肌瘤体积及子宫体积、宫腔镜手术时间、出血量及并发症。结果HIFU术后1例肌瘤完全排出，1例部分排出，3例转为0型（273 %，3/11），6例转为I型（545 %，6/11）。HIFU前患者肌瘤最大径平均（5508±993）mm，肌瘤体积平均（6860±3627）cm3，子宫体积平均（22226±5476）cm3。HIFU后患者肌瘤最大径平均（4008±1575）mm，肌瘤体积平均（3300±2106）cm3，子宫体积平均（16196±4318）cm3。HIFU后患者肌瘤最大径、肌瘤体积及子宫体积均显著缩小，差异有统计学意义（P＜005）。宫腔镜手术平均出血量（2500±1162）mL，平均手术时间（3091±1300）min。结论HIFU联合宫腔镜治疗直径＞4 cm的Ⅱ型黏膜下肌瘤有较高的安全性和有效性，对较大Ⅱ型黏膜下肌瘤，HIFU可以作为较好的预处理方式。
Abstract:
ObjectiveTo investigate the efficacy and safety of high intensity focused ultrasound(HIFU) combined with hysteroscope in the treatment of type II submucous myoma with diameter >4 cm.MethodsFrom January to June 2019, 12 cases of type II submucous myoma with diameter 4~8 cm diagnosed by transvaginal ultrasound or magnetic resonance imaging were treated with HIFU. The changes of myoma were analyzed 3 months after operation. Hysteroscopic hysteroscopic resection of uterine myoma was performed. Hemoglobin，the maximum diameter of myoma, the volume of myoma and uterine, the time of hysteroscopy, the amount of bleeding and complications were recorded before and after HIFU.ResultsAfter HIFU, 1 case of myoma was completely discharged,and 1 case was partially discharged. 3 cases were converted to type 0 (273 %,3/11), and 6 cases were converted to type I (545 %,6/11). The mean maximum diameter of myoma was (5508±993)mm,and the average volume of myoma was (6860±3627)cm3, and the average volume of myoma was (22226±5476)cm3.Through the therapy, the mean maximum diameter of myoma was (4008±1575)mm, and the mean volume of myoma was (3300±2106)cm3, and the average volume of uterus was (16196±4318)cm3.These observations talked above were significantly reduced after HIFU,and the differences were statistically significant (P<005). The average blood loss during hysteroscopic surgery was (2500±1162) mL, and the mean operation time was (3091±1300)min.ConclusionHIFU combined with hysteroscopy is safe and effective in the treatment of type II submucous myoma with diameter >4 cm.It can be used as a better pretreatment method for large type II submucous myoma.

参考文献/References:

［1］谢幸，孔北华，段涛．妇产科学 ［M］．第9版．北京：人民卫生出版社，2018：303306． ［2］ChabbertBuffet N, Nathalie E, Bouchard P. Fibroid growth and medical options for treatment ［J］. Fertility and Sterility, 2014, 102(3): 630639. ［3］中华医学会妇产科分会妇科内镜学组．妇科宫腔镜诊治规范 ［J］．中华妇产科杂志，2012，47（7）：555558． ［4］Lagana A S, Pacheco L A, Tinelli A, et al. Management of asymptomatic submucous myomas in women of reproductive age: a consensus statement from the global congress on hysteroscopy scientific committee ［J］. Journal of Minimally Invasive Gynecology, 2019, 26(3): 381383. ［5］Chen Jinyun, Chen Wenzhi, Zhang Lian, et al. Safety of ultrasoundguided ultrasound ablation for uterine fibroids and adenomyosis: A review of 9988 cases ［J］. Ultrasonics Sonochemistry, 2015, 27: 671676. ［6］Chen Yan, Jiang Jing, Zeng Yuhua, et al. Effects of a microbubble ultrasound contrast agent on highintensity focused ultrasound for uterine fibroids: a randomised controlled trial ［J］. International Journal of Hyperthermia, 2018, 34(8): 13111315. ［7］American Association of Gynecologic Laparoscopists : Advancing Minimally Invasive Gynecology W. AAGL practice report: practice guidelines for the diagnosis and management of submucous leiomyomas ［J］. J Minim Invasive Gynecol.2012, 19(1):152171. ［8］张春妮，莫锐婷．GnRHa用于大黏膜下子宫肌瘤宫腔镜手术前临床观察 ［J］．深圳中西医结合杂志，2017,27（17）：174175． ［9］Ying Zhang, Li Sun, Guo Yinshu, et al. The impact of preoperative gonadotropinreleasing hormone agonist treatment on women with uterine fibroids ［J］. Obstetrical & Gynecological Survey, 2014, 69(2): 100108. ［10］Muzii L, Boni T, Filippo B, et al. GnRH analogue treatment before hysteroscopic resection of submucous myomas: a prospective, randomized, multicenter study ［J］. Fertility and Sterility, 2010, 94(4): 14961499. ［11］Garzon S, Ukybassova T, Terzic M, et al. Evaluation of uterine artery embolization on myoma shrinkage: Results from a large cohort analysis ［J］. Gynecology and Minimally Invasive Therapy, 2019, 8(4): 165. ［12］黄燕．子宫动脉栓塞联合宫腔镜治疗巨大子宫黏膜下肌瘤的疗效分析 ［J］．中国社区医师，2018,34（29）：3839． ［13］陈春林．子宫动脉栓塞治疗子宫肌瘤的适应证及临床疗效 ［J］．实用妇产科杂志，2007，23（12）：714716． ［14］Van der Kooij SM, Hehenkamp WJ, Volkers NA, et al.Uterine artery embolization vs. hysterectomy in the treatment of symptomatic uterine fibroids:5 years outcome from the randomized EMMY trial ［J］. Am J Obstet Gynecol,2010,203:105113. ［15］Gingold J A,Gueye N A,Falcone T.Minimally Invasive Approaches to Myoma Management［J］.Journal of Minimally Invasive Gynecology,2017,25(2). ［16］Vercellini P,Carmignani L,Rubino T,et al.Surgery for Deep Endometriosis:A PathogenesisOriented Approach ［J］. Gynecologic & Obstetric Investigation,2009,68(2):88103. ［17］李发琪，王智彪，杜永洪，等．高强度聚焦超声“切除”组织的剂量学研究 ［J］．生物医学工程学杂志，2006，23（4）：839843． ［18］何佳．子宫黏膜下肌瘤高强度聚焦超声治疗 ［J］．中国实用妇科与产科杂志，2016,32（2）：145148． ［19］周鑫．超声消融疗法在子宫黏膜下肌瘤治疗中的疗效分析及安全性评估 ［J］．中国实用医刊，2014，41（19）：9091． ［20］Lee J S, Hong G Y, Lee K H, et al. Safety and efficacy of ultrasoundguided highintensity focused ultrasound treatment for uterine fibroids and adenomyosis ［J］. Ultrasound in Medicine & Biology, 2019, 45(12): 32143221. ［21］Qu Dacheng,Yan Chen,Yang Maomei,et al.Highintensity focused ultrasound for treatment of type 2 submucous myomas more than 4 centimeters in diameter prior to hysteroscopic myomectomy ［J］.Journal of Minimally Invasive Gynecology,2020,27(5):10761080. ［22］黄流海，黄国华，何佳．高强度聚焦超声在子宫黏膜下肌瘤治疗中的临床效果分析 ［J］．中国医药科学，2017,7（16）：6871． ［23］Camanni M, Bonino Luca, Delpiano E M, et al. Hysteroscopic management of large symptomatic submucous uterine myomas ［J］. Journal of Minimally Invasive Gynecology, 2010, 17(1): 5965. ［24］Wang Wei, Wang Yang, Wang Ting, et al. Safety and efficacy of USguided highintensity focused ultrasound for treatment of submucosal fibroids ［J］. European Radiology, 2012, 22(11): 25532558.

相似文献/References:

[1]陈锦云,王智彪.子宫肌瘤的消融与介入治疗[J].中国计划生育和妇产科,2012,(03):0.
　CHEN Jin-yun,WANG Zhi-biao * Chongqing Medical University,Chongqing 000,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2012,(9):0.
[2]董英辉,段亚男,白文彩,等.高强度聚焦超声治疗子宫肌瘤[J].中国计划生育和妇产科,2012,(05):0.
　DONG Ying-hui,DUAN Ya-nan,BAI Wen-cai,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2012,(9):0.
[3]毛世华,谭晓燕,范玲,等.高强度聚焦超声联合米非司酮治疗子宫腺肌病的疗效观察[J].中国计划生育和妇产科,2014,(05):0.
　MAO Shi-hua,TAN Xiao-yan,FAN Ling,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2014,(9):0.
[4]邓云,丁惠,许永华,等.高强度聚焦超声治疗子宫腺肌病病灶消融率影响因素分析[J].中国计划生育和妇产科,2015,(06):0.
　DENG Yun,DING Hui,XU Yong-hua,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2015,(9):0.
[5]郭清,徐锋,丁珍珍,等.高强度聚焦超声治疗子宫腺肌病3种方案的疗效对比研究[J].中国计划生育和妇产科,2016,(09):0.
　GUO Qing,XU Feng,DING Zhen-zhen,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2016,(9):0.
[6]郭清,丁珍珍,徐锋,等.高强度聚焦超声在妇科疾病中的应用[J].中国计划生育和妇产科,2016,(10):0.
[7]熊小娟,傅义红*,胡 泊,等.高强度聚焦超声与腹腔镜、开腹剔除治疗子宫肌瘤中远期复发及妊娠的比较[J].中国计划生育和妇产科,2017,(6):40.
　XIONG Xiao-Juan,FU Yi-Hong*,HU Bo,et al.Comparison of high intensity focused ultrasound,laparoscopic and open abdomen in the treatment of long-term recurrence and pregnancy in uterine fibroids[J].Chinese Journal of Family Planning & Gynecotokology,2017,(9):40.
[8]章香春*,陈慧敏.高强度聚焦超声治疗子宫肌瘤171例临床并发症分析及预防处理[J].中国计划生育和妇产科,2017,(7):37.
　ZHANG Xiang-chun*,CHEN Hui-min.Analysis of clinical complications and preventive measures of 171 cases of uterine fibroids treated by high intensity focused ultrasound[J].Chinese Journal of Family Planning & Gynecotokology,2017,(9):37.
[9]杨琳,丁立*,代倩苓.运用辅助检查评估高强度聚焦超声治疗剖宫产瘢痕妊娠的临床价值[J].中国计划生育和妇产科,2017,(8):47.
　YANG Lin,DING Li*,DAI Qian-ling.Discussion on the clinical value of high intensity focused ultrasound in the treatment of cesarean section scar pregnancy with auxiliary examination[J].Chinese Journal of Family Planning & Gynecotokology,2017,(9):47.
[10]杜成超,周洪贵*.核磁共振成像在高强度聚焦超声治疗子宫腺肌病中的价值[J].中国计划生育和妇产科,2018,(4):30.

更新日期/Last Update: 2020-09-25